Junqing Yan

ORCID: 0000-0003-2012-5516
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Gastroesophageal reflux and treatments
  • Gut microbiota and health
  • Ferroptosis and cancer prognosis
  • MicroRNA in disease regulation
  • Eosinophilic Esophagitis
  • Lipid metabolism and disorders
  • Platelet Disorders and Treatments
  • Extracellular vesicles in disease
  • Glioma Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Gastrointestinal motility and disorders
  • Intracranial Aneurysms: Treatment and Complications
  • Cancer-related molecular mechanisms research
  • Diet, Metabolism, and Disease
  • Animal Virus Infections Studies
  • Nutrition and Health in Aging
  • COVID-19 epidemiological studies
  • Systemic Sclerosis and Related Diseases
  • Cancer, Lipids, and Metabolism
  • Cerebrovascular and Carotid Artery Diseases
  • Esophageal and GI Pathology

Tianjin Third Central Hospital
2017-2025

Tianjin Medical University
2017-2025

Ruijin Hospital
2024-2025

Tongji Hospital
2021-2024

Tongji University
2022-2024

Tianjin Hospital
2022

Tianjin Fire Research Institute
2017

ABSTRACT Objectives Intracranial aneurysm (IA) poses a significant health risk, and its formation involves various factors, including lipid metabolism, while former research only focused on the standard lipid. The purpose of this study is to explore 179 variants' impact unruptured intracranial aneurysms (uIA). Materials Methods Utilizing GWAS data for lipids uIAs, MR analyses were employed with pleiotropy, heterogeneity, sensitivity tests. Reverse then conducted. Results revealed seven...

10.1002/brb3.70435 article EN cc-by Brain and Behavior 2025-03-01

Patients with acute-on-chronic liver failure (ACLF) have a high mortality rate, poor prognosis, and often experience concurrent thrombocytopenia bleeding events. To evaluate the efficacy safety of recombinant human thrombopoietin (rhTPO) in patients ACLF concomitant severe thrombocytopenia. This was prospective, open-label study. We assigned 70 into rhTPO group control group, 35 each group. received subcutaneous injections at dose 15000 IU/day for 7 consecutive days, while did not receive...

10.3748/wjg.v31.i14.105004 article EN World Journal of Gastroenterology 2025-04-09

We aimed to investigate sleep quality, mild hepatic encephalopathy, anxiety, and depression in patients with hepatitis B cirrhosis by using a variety of scales questionnaires.A cohort 341 liver were categorized Child-Pugh grading (A, B, C) this cross-sectional study. Pittsburgh Sleep Quality Index (PSQI), Number Connection Test-A (NCT-A), Hospital Anxiety Depression (HAD) evaluated the questionnaires statistically analyzed intrinsic correlation. The control group included 50 healthy...

10.1111/hepr.12981 article EN Hepatology Research 2017-09-09

This study employed Mendelian randomization (MR) analysis to systematically investigate the potential connections between gut microbiota and risk of glioblastoma (GBM). We identified 12 microbial groups closely associated with incidence GBM. Subsequently, MR was conducted on 1,091 blood metabolites 309 metabolite ratios, revealing 19 that exert an impact occurrence Hypothesizing may influence multiforme by modulating these metabolites, we performed analyses, considering each group as...

10.3389/fneur.2024.1386885 article EN cc-by Frontiers in Neurology 2024-07-03

Aim The present study aimed to evaluate the durability of immune response after basic and booster immunization with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients chronic liver disease (CLD). Methods Patients CLD complete or SARS-CoV-2 were included this study. Based on vaccination situation, they divided into immunity group (Basic) (Booster), which then subdivided four groups according time interval from completion serological specimen collection. positive...

10.3389/fimmu.2023.1200198 article EN cc-by Frontiers in Immunology 2023-06-15

Abstract Numerous studies have explored the various functions of SLC40A1 in cancer development. However, role primary glioblastoma necessitates further investigation. Initially, we observed that GBM patients with high expression had a more favorable prognosis compared to those low levels, as evidenced by analysis TIMER database. Subsequent using TCGA database enabled us identify potential mechanisms. Further analyses, including GO, KEGG, GSEA, immune infiltration, and correlation revealed...

10.21203/rs.3.rs-3872535/v1 preprint EN cc-by Research Square (Research Square) 2024-01-25

Abstract Aim we examined the humoral immune response and antibody dynamics after primary booster vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among patients with chronic liver disease (CLD). Methods We enrolled confirmed CLD SARS-CoV-2 or immunity. Following immunity, serological samples were gathered to detect novel neutralizing antibodies (nCoV NTAb) spike receptor-binding proteins S-RBD). Results The positive rate of nCoV NTAb was 60.1% in Primary 87.6%...

10.1101/2022.11.12.22282242 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-11-14

Background Cases of duodenal variceal hemorrhage after cirrhosis are rare, but patients have a higher mortality rate. There is currently no clinical guideline to address how such should choose preferred treatment. Methods We retrospectively evaluated the information 65-year-old male admitted Gastroenterology Department with gastrointestinal bleeding. Results The patient was eventually diagnosed bleeding cirrhosis. performed TIPS on vital signs were stable. No varicose veins seen by endoscopy...

10.7754/clin.lab.2019.191130 article EN Clinical Laboratory 2020-01-01

ABSTRACT This article is aim to investigate the safety and immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster in patients with chronic liver disease(CLD). A total 114 CLD who received a SARS-CoV-2 were enrolled this study. Serum samples collected from at least 14 days after dose tested for neutralizing antibody (novel antibody, nCoV NTAb) IgG against spike binding domain receptor-binding S-RBD antibody) levels. The positive rates NTAb 87.72%...

10.1101/2022.10.30.22281713 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2022-11-01

The high prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) have become a global medical concern. Compared with obesity, metabolic abnormalities may be more critical. Currently, there is lack relevant data for nutritional status energy characteristics in patients obese lean NAFLD.

10.5152/tjg.2021.20908 article EN The Turkish Journal of Gastroenterology 2021-05-05
Coming Soon ...